HCA Healthcare holder plans 42,877-share sale

HCA Healthcare, Inc. common stock: a shareholder has filed a Form 144 to sell 42,877 common shares through Merrill Lynch on the NYSE, with an aggregate market value of 21483273.66.

Rhea-AI Filing Summary

HCA Healthcare, Inc. common stock: a shareholder has filed a Form 144 to sell 42,877 common shares through Merrill Lynch on the NYSE, with an aggregate market value of 21483273.66.

The shares were acquired on 01/30/2026 by exercising a stock appreciation right granted by HCA Healthcare, Inc., with compensatory payment as consideration. The planned sale date is approximately 02/03/2026, and the filing notes 228,193,900 common shares outstanding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HCA Form 144 filing disclose about share sales?

The Form 144 shows a planned sale of 42,877 HCA Healthcare common shares through Merrill Lynch on the NYSE. The aggregate market value of these shares is about 21483273.66, with an approximate sale date of 02/03/2026.

How were the 42,877 HCA (HCA) shares being sold acquired?

The 42,877 HCA Healthcare common shares were acquired on 01/30/2026 through the exercise of a stock appreciation right. HCA Healthcare, Inc. is listed as the party from whom the securities were acquired, and the consideration is described as a compensatory payment.

What is the market value of the HCA shares in this Form 144?

The Form 144 lists an aggregate market value of 21483273.66 for the 42,877 HCA Healthcare common shares to be sold. This value helps quantify the size of the planned transaction relative to typical insider or affiliate sales.

On which exchange and through which broker will the HCA shares be sold?

The filing states the HCA Healthcare common shares will be sold on the NYSE through Merrill Lynch. The broker’s address is given as 3455 Peachtree Road NE, Suite 1000, Atlanta, GA 30326, indicating a standard broker-facilitated market transaction.

How many HCA Healthcare shares are outstanding in this Form 144?

The Form 144 notes that 228,193,900 HCA Healthcare common shares are outstanding. This figure provides a baseline for understanding the relative size of the 42,877-share planned sale compared with the company’s total common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001216838
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HCA Healthcare, Inc.
SEC File Number	001-11239
Address of Issuer	One Park Plaza Nashville TENNESSEE 37203
Phone	6153449551
Name of Person for Whose Account the Securities are To Be Sold	Samuel N. Hazen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	President, Chief Executive Officer & Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3455 Peachtree Road NE STE 1000 Atlanta GA 30326	42877	21483273.66	228193900	02/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/30/2026	Exercise of a Stock Appreciation Right	HCA Healthcare, Inc.			42877	01/30/2026	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Samuel N. Hazen
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)